A Side of Salmonella Superbug With That Turkey Burger? (UPDATED)

<a href="http://www.flickr.com/photos/m500/3014035866/sizes/m/in/photostream/">Joe Marinaro</a>/Flickr

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


UPDATE: Marler Blog reported Wednesday afternoon that agribusiness behemoth Cargill is behind the tainted turkey. The company will soon announce a voluntary recall of nearly 36 million pounds of ground-turkey products, the blog reports, all of which emerged from a single processing facility in  Springdale, Arkansas. This latest fiasco does not mark the first time Cargill has sent out massive amounts of product potentially tainted with antibiotic-resistant salmonella. In 2009, a beef processor owned by the company had to recall 826,000 pounds of hamburger meat laced with a resistant strain called salmonella Newport. For good measure, the same plant had to recall another 22,000 pounds for the same reason a few months later. A USA Today investigation revealed that the troubled plant was a major supplier to the national school lunch program. Cargill, among the globe’s largest privately held companies, processes about 25 percent of the beef consumed in the United States, along with 14 percent of the turkey and 9 percent of the pork.


Once again, a drug-resistant “superbug” has infiltrated the national food supply. This time, the culprit appears to be tainted ground turkey, although federal investigators have not been able to definitively identify the source and thus have not issued a recall. The Centers for Disease Control reports that 77 people in 26 states have fallen ill; one person has died. Here’s how the CDC describes the situation:

The outbreak strain of Salmonella Heidelberg is resistant to many commonly prescribed antibiotics; this antibiotic resistance can increase the risk of hospitalization or possible treatment failure in infected individuals. [Emphasis added.]

“Treatment failure,” of course, is a polite way of saying “death.”

Such outbreaks are almost certainly related to the meat industry’s practice of giving confined livestock daily antibiotic doses, both to keep them functioning under cramped, unsanitary conditions and to make them grow faster. Will this outbreak finally force federal regulators to crack down on this practice? Doubtful.

As I reported last week, the USDA recently acknowledged the factory farm/antibiotic-resistance link in a “technical review” of the latest peer-reviewed science on the topic. But instead of throwing its weight behind a crackdown of factory-farm antibiotic abuse, the agency unceremoniously stepped on the report, removing it from its website without explanation after meat-industry groups complained about it.

Then there’s the FDA. As the agency that regulates pharmaceuticals, the FDA could act to protect the public from drug-resistant pathogens by limiting their use at factory farms. The agency strongly and publicly acknowledged the link back in 2009. Yet it maintains its official stance that antibiotics should be “used judiciously” on factory farms, and it leaves it to the industry to define what that means.

In other words, our federal watchdogs know what’s causing deadly outbreaks like the current one; they’ve just decided not to do anything to prevent them. A 2010 poll by the Union of Concerned Scientists and Iowa State University may explain why. The pollsters got 1,700 USDA and FDA employees to respond to a detailed questionnaire about industry influence on their agencies’ decision making. The results are nearly as sickening as a tainted turkey burger:

Hundreds of survey respondents identified undue corporate influence as a major problem. More than 620 respondents (38 percent) agreed or strongly agreed that “public health has been harmed by agency practices that defer to business interests.”…And more than 300 respondents (25 percent) said they personally experienced corporate interests forcing their agency to withdraw or significantly modify a policy or action designed to protect consumers in the past year. When asked that same question about Congress and non-governmental interests, more than 260 respondents (24 percent) and more than 240 respondents (22 percent) said yes, respectively.

In the absence of the backbone required to stand up to industry, the USDA—which oversees the safety of meat products—can only issue “voluntary recalls” of products that have been infected with antibiotic-resistant pathogens: a desperate attempt to slam the barn door shut after the tainted cows have escaped. In this case, the agency can’t even take that feeble action, because investigators still haven’t been able to trace the outbreak to a specific product. In the absence of a “voluntary recall,” the USDA is left to “remind consumers of the critical importance of following package cooking instructions for frozen or fresh ground turkey products.” In other words, sorry folks—you’re on your own.

Meanwhile, scientists in Europe have identified yet another new strain of “super” salmonella, this one resistant to a range of antibiotics, including the powerful one known as Cipro, Reuters reports. The strain appears to thrive in poultry farms in Africa, where US-style factory livestock farming is being hotly promoted. According to Reuters, researchers have found the strain in chickens and turkeys from Ethiopia, Morocco, and Nigeria, where heavy antibiotic use in poultry production “may have contributed to this rapid spread.”

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate